Be Ready to Manage Ketoacidosis Due to an SGLT2 Inhibitor
November 2023
You’ll get questions about how to manage euglycemic ketoacidosis due to SGLT2 inhibitors...as their use increases.
Ketoacidosis due to an SGLT2 inhibitor (SGLT2i) is rare...occurring in less than 0.1% of patients. And it’s easy to overlook...blood glucose is often normal or only slightly elevated.
Identification. Be alert for possible triggers of ketoacidosis in patients taking an SGLT2i, such as fasting...infection...reducing insulin doses...or surgery.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote